Transcutaneous Electrical Nerve Stimulation for Endometriosis-related

Status Recruiting

Clinical Trial Summary

The study evaluates the effect of TENS (transcutaneous electrical nerve stimulation) as add-on treatment compared with conventional analgesic treatment in patients with endometriosis-related chronic pain. Patients with frequent pain and high pain intensity will be randomized to additional treatment with TENS or conventional treatment for 8 weeks to evaluate the acute effects of TENS treatment (n=40). Patients with endometriosis-related pain that is not frequent or without high pain intensity constitute an external control group. All patients in the study will receive TENS treatment for a total of 16 weeks, for evaluation of long-term effects of TENS treatment.

Clinical Trial Description

Endometriosis affects approximately one in ten women of childbearing age and may involve both acute pain related to the menstrual cycle and chronic pain. Usual analgesic therapy is often inadequate and/or involves unacceptable side effects and risks with long-term use. Transcutaneous electrical nerve stimulation (TENS) is a patient controlled treatment for pain relief with few side-effects. To date there is limited knowledge of how TENS treatment should be carried out for optimal pain relief in this patient group. The aim of the study is asses the effect of TENS as add-on treatment compared with conventional analgesic treatment in patients with endometriosis-related chronic pain. Patients with frequent pain and high pain intensity (≥ 4 according to Numeric Rating Scale, NRS) will be randomized to additional treatment with TENS or conventional treatment for 8 weeks in order to evaluate the acute effects of TENS treatment (n=40). Patients with endometriosis-related pain that is not frequent or without high pain intensity constitute an external control group. All patients in the study will receive TENS treatment for a total of 16 weeks, for evaluation of long-term effects of TENS treatment in chronic endometriosis-related pain. Prior to start of TENS treatment, all patients receive education on chronic endometriosis-related pain and TENS treatment. Study participants will be asked to participate in a qualitative follow-up within the study including a semi-structured individual interview (n=10-15) before intervention and a semi-structured focus group (n=9-15) interview after completion of TENS treatment. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05152264
Study type	Interventional
Source	Göteborg University
Contact	Paulin Andréll, MD, PhD
Phone	+46-31-3438259
Email	paulin.andrell@gu.se
Status	Recruiting
Phase	N/A
Start date	November 12, 2021
Completion date	December 2025

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT04179149` - Enriched Environments in Endometriosis	N/A
Completed	`NCT03654326` - A Study to Evaluate the Efficacy and Safety of Gefapixant (MK-7264) in Women With Endometriosis-Related Pain (MK-7264-034)	Phase 2
Recruiting	`NCT04554693` - The Use of Low Dose Metronidazole to Decrease Postoperative Pain After Endometriosis Surgery	Phase 4
Recruiting	`NCT06214260` - Menstrual Blood Proteomic Profile in Women With Endometriosis (PROTEO-ENDO) Study
Recruiting	`NCT05978414` - Functional Links Between the Temporomandibular Joint and the Pelvis in Gynecology	N/A
Completed	`NCT04440397` - Relationship Between Endoplasmic Reticulum Stress and Pain in Patients With Endometriosis
Completed	`NCT04370444` - Pathways for Patient-centered Diagnosis and Management of Endometriosis-associated Deep Dyspareunia	N/A
Recruiting	`NCT05367258` - Umbilical Endometriosis: a Comparison of Medical and Surgical Therapy and Pathogenetic Considerations
Completed	`NCT05527002` - Thoracic Endometriosis: A Cohort Study
Recruiting	`NCT05754190` - Assessing Symptom and Mood Dynamics in Pain Using the Smartphone Application SOMA
Recruiting	`NCT04728152` - Evaluation of miRNAs in Endometriosis
Completed	`NCT04883073` - Impact on Quality of Life of "Endo-App" (ELEA)	N/A
Active, not recruiting	`NCT04204707` - Patient Reported Outcomes After Surgery for Rectal Endometriosis
Completed	`NCT03692403` - Randomized Trial Assessing Quinagolide Vaginal Ring for Endometriosis-related Pain	Phase 2
Recruiting	`NCT06286371` - Pelvic Neuro-Angiogenesis in Deep Endometriosis	N/A
Not yet recruiting	`NCT04491305` - EHP-5 in Preoperative Assessment in Women With Endometriosis
Recruiting	`NCT05433909` - Microbiota and Immunoassay in Women With and Without Endometriosis: a Pilot Study	N/A
Recruiting	`NCT05496218` - Metabolomic Profile in Women With and Without Endometriosis	N/A
Recruiting	`NCT05362838` - Conventional Laparoscopy Versus Robotic Surgery for Pain Relief in Patients With Deep Infiltrating Endometriosis	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Transcutaneous Electrical Nerve Stimulation for Endometriosis-related Chronic Pain

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms